Related Experiment Video
Updated: Apr 24, 2026

A RAPID Method for Blood Processing to Increase the Yield of Plasma Peptide Levels in Human Blood
Published on: April 28, 2016
Hesperidin potentiates ghrelin signaling
Hajime Suzuki, Akihiro Asakawa, Namiko Kawamura
1Department of Psychosomatic Internal Medicine, Kagoshima University Graduate School of Medical and Dental Sciences, 8-35-1 Sakuragaoka, Kagoshima, 890-8520, Japan.. asakawa@m2.kufm.kagoshima-u.ac.jp.
Hesperidin, a citrus fruit compound, influences ghrelin secretion, impacting appetite and gut motility. This review explores its orexigenic and prokinetic effects, highlighting potential therapeutic applications for various diseases.
Area of Science:
- Biochemistry
- Pharmacology
- Nutritional Science
Background:
- Hesperidin is a flavanone glycoside found in citrus fruits.
- It exhibits diverse biological activities, including anti-cancer, antimicrobial, and antiviral effects.
- Previous research suggests hesperidin influences ghrelin secretion via serotonin receptor antagonism.
Purpose of the Study:
- To review studies on the orexigenic and prokinetic activities of hesperidin.
- To explore the role of hesperidin in ghrelin secretion.
- To present relevant patents concerning hesperidin.
Main Methods:
- Literature review of existing studies on hesperidin.
- Analysis of research on hesperidin's effects on ghrelin secretion.
- Examination of patents related to hesperidin applications.
Main Results:
- Hesperidin demonstrates potential orexigenic (appetite-stimulating) and prokinetic (gut motility-enhancing) properties.
- Its mechanism may involve the modulation of ghrelin secretion.
- Several patents highlight hesperidin's therapeutic potential.
Conclusions:
- Hesperidin shows promise as a therapeutic agent for conditions involving appetite regulation and gastrointestinal motility.
- Further research into hesperidin's role in ghrelin pathways is warranted.
- Its natural origin and diverse bioactivities make it an attractive compound for drug development.
Related Concept Videos
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
Regulation of Food Intake
GPCRs Regulate Adenylyl Cylase Activity
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
Hormonal Regulation
GPCR Desensitization

